Effect of pollutants upon patients with respiratory allergies by Dávila, I. et al.
 J Investig Allergol Clin Immunol 2007; Vol. 17, Suppl. 2: 9-20© 2007 Esmon Publicidad
Effect of pollutants upon patients with 
respiratory allergies 
I Dávila,1 J Mullol,2 J Bartra,3 A del Cuvillo,4 M Ferrer,5 I Jáuregui,6 
J Montoro,7 J Sastre,8 A Valero3
1 Service of Immunoallergy, Hospital Clínico, Salamanca, Spain
2 Rhinology Unit, ENT Service (ICEMEQ), Hospital Clínic, Barcelona, Spain
3 Allergy Unit, Service of Pneumology and Respiratory Allergy, Hospital Clínic (ICT), Barcelona, Spain
4 Clínica Dr. Lobatón, Cádiz, Spain 
5 Department of Allergology, Clínica Universitaria de Navarra, Pamplona, Spain
6 Service of Allergy, Hospital de Basurto, Bilbao, Spain
7 Allergy Unit, Hospital La Plana, Villarreal (Castellón), Spain
8 Service of Allergy, Fundación Jiménez Díaz, Madrid, Spain
■ Summary
Epidemiological studies have revealed an association between pollution and allergic respiratory diseases. The main pollutants in this sense 
are nitric oxide, ozone, and particulate matter. The present review on one hand addresses the chemical characteristics of each of these three 
groups of pollutants and their main sources, and on the other examines their effects upon allergic respiratory diseases - placing special 
emphasis on the effects of diesel exhaust particles. For each of the pollutants, the underlying mechanisms capable of infl uencing allergic 
respiratory diseases are commented. Lastly, an evaluation is made of some of the genetic aspects related to the response to pollutants.
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Introduction
Technical and industrial development has led to a 
signifi cant increase in the world population and its quality 
of life, though with considerable differences depending on 
the geographical location. However, industrialization and the 
technological revolution have not taken place without collateral 
effects for the environment in which such activities occur. 
Globally, such effects can be considered to result from what 
we call environmental pollution. The dictionary defi nes (as fi rst 
option) the term “pollution” as the “alteration or damage of some 
substance, or its effects upon the purity or state of something”. 
In its third defi ning option, pollution is taken to be “intense and 
harmful damage to water or air, caused by the waste of industrial 
or biological processes”. In the medical setting, pollution refers 
to the effects upon human health of such alterations in water or 
air. In allergology, pollution can have repercussions in two ways: 
upon people, altering their health; or upon allergens, altering 
their composition, allergenicity or production. The present 
review will center on the fi rst of these aspects. 
■ Resumen
Los estudios epidemiológicos muestran una asociación entre la contaminación y las enfermedades alérgicas respiratorias. Los principales 
agentes contaminantes son el óxido nítrico, el ozono y las partículas en suspensión. En esta revisión se comentan, por un lado, las 
características químicas de cada uno de esos tres grupos de contaminantes y sus fuentes principales y, por otro, los efectos que ejercen 
sobre las enfermedades alérgicas respiratorias , prestando especial atención a  los efectos de las partículas derivadas de la combustión 
de los motores diesel. Para cada uno de los agentes contaminantes, se comentan los posibles mecanismos subyacentes capaces de infl uir 
sobre las enfermedades alérgicas respiratorias. Por último, se evalúan algunos aspectos genéticos relacionados con la respuesta a los 
agentes contaminantes.
Palabras clave: Alergia. Ozono. Óxido nítrico. Partículas en suspensión. Asma.
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In the last quarter of a century, there have been important 
advances in our knowledge of the effects of pollutants upon health 
considered globally, and upon certain allergic disease in particular. 
This knowledge has in part reached the general public, which 
is showing a growing interest in the subject. Thus, an informed 
patient may for example ponder whether pollution can increase 
the risk of developing asthma or allergy, or of exacerbating 
such a disorder; or how to prevent the effects of environmental 
pollution (questions, for example, regarding whether air pollution 
can infl uence childhood asthma, or how to avoid or prevent its 
effects). It is therefore important for the physician to be able to 
answer these and other patient concerns.
Air pollutants
Environmental pollutants can be classifi ed in different 
ways: 1) according to whether they require transformation or 
not (primary and secondary); 2) according to their composition 
(gases or particulate matter); or 3) according to their location 
(outdoor and indoor) [1]. Depending on whether they require 
prior transformation or not, pollutants are classifi ed as primary 
agents - these being the contaminants released directly into 
the atmosphere, such as SO
2
 - or secondary agents (i.e., those 
formed in the atmosphere as a result of chemical reaction 
with other contaminants or gases such as ozone) (Table 1). 
Particulate matter (PM) is usually also classifi ed according 
to size (see below).
The main sources of pollution tend to be human, i.e., 
anthropogenic. Of these sources, the most important is the 
combustion of fossil fuels. In urban areas and in much of the 
suburban setting, the main source of pollutants is motor vehicle 
combustion. These emissions (vehicle exhaust) constitute 
a complex mixture of chemical compounds, including for 
example organic compounds derived from diesel exhaust, PM 






 [2]. Other sources 
of pollution are industries and energy producing facilities 
- particularly those that use coal. The most important natural 
source of pollution is represented by fi res. 
The fundamental pathway for exposure to these pollutants 
is inhalation [3] - hence their importance in relation to 
allergic respiratory diseases such as asthma. Other less 
important sources are water and soil pollution secondary to 
accumulation and rainfall (precipitation) - taking into account 
that some pollutants can accumulate and persist in these 
settings, since their degradation takes place at a slower rate.
A description is provided below of the main pollutants, 
NO
2
, ozone and PM, with an account of their main 
characteristics and an analysis of their effects upon 
allergic respiratory diseases - placing special emphasis 
on asthma, since this is the most widely studied and best 
known representative of such disorders. In general, studies 
conducted in animals will be avoided, centering attention on 
the review of the available data obtained from human studies. 
Nevertheless, it should be mentioned that under conditions of 
normal clinical practice, particles and gases form a complex 
mixture, and close interactions may exist among the different 
pollutants. Tables 2 and 3 report the limiting values for these 
pollutants according to current Spanish legislation.
10
(*) SVOC: specifi c volatile organic compounds
1. Nitrogen compounds
Nitrogen compounds are present in the atmosphere in 
both oxidized and reduced form. The reduced forms include 
ammonia (NH
3
) and ammonium (NH
4
). The oxidized forms in 
turn include nitric oxide (N
2
O), nitrogen oxide (NO), nitrogen 
dioxide (NO
2
), nitrous acid (HNO
2
), nitric acid (HNO
3
), 





 is defi ned as NO + NO
2
 [4]. Most nitrogen oxides are 
released into the atmosphere in the form of NO, which is 
transformed relatively quickly into NO
2
 through reaction with 




. Of the different 
nitrogen compounds, NO
2
 is the most important in terms of 
impact upon health. 
NO
2
 can be generated from natural sources (bacterial 
activity in the soil, volcanoes, lightning) - though in the 
European setting anthropogenic sources are the most important. 
Motor vehicles - both diesel and gasoline - together with 
coal- and petroleum-burning energy plants are the main 
Table 1. Classifi cation of air pollutants
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a recent study found no association between personal exposure 
to NO
2
 and peak respiratory fl ow values in asthmatic adults [9], 
while in other cases the results were inconclusive [10,11]. In 
addition, it must be taken into account that the effect of a given 
pollutant is diffi cult to distinguish from the effects of other 
pollutants to which the former is often associated. In Valencia 
(Spain), Tenias et al. [12] found an association between 
source of nitrogen oxides. The higher the temperature and 
combustion pressure, the greater the production of nitrogen 
oxides. Nitrogen dioxide (NO
2
) is a brownish-red and toxic 
gas responsible for the photochemical haze known as smog. 
In association with SO
2
, it is also responsible for acid rain. 
The gas concentrates mainly in the urban setting, though the 
levels are highly variable, depending on the zone. The levels 
of NO
2
 are a reasonable marker of exposure to motor vehicle 
traffi c. In the rural setting the concentrations are much lower 
and depend on the distance to the source. The cycle of nitrogen 
compounds in the urban setting is complex, and is shown in 
Figure 1. There is no linear correlation between the levels of 
NOx and NO
2
. In general, indoor concentrations are usually 
30-100% of the outdoor concentrations.
1.1. Effects of NO2.  NO2 exerts its effects upon health over 
both the short and long term. Short-term exposure to very high 
levels of NO
2
 can have important pulmonary repercussions in 
healthy subjects. In people with chronic lung diseases such as 
asthma or chronic obstructive pulmonary disease (COPD), the 
threshold is lower, and responses can be seen at short term, 
such as increased bronchial hyper-responsiveness [4]. Chronic 
exposure to NO
2
 can be associated with increased respiratory 
symptoms. Nevertheless, it may be diffi cult to distinguish 
whether the observed effects are the result of short- or long-
term exposure to the pollutant. 
Some epidemiological studies have associated NO levels 
to visits to the emergency service due to asthma attacks [5,6], 
or NO
2
 indoor concentrations to asthma exacerbation [7,8]. 
However, there is a disparity of results in the literature. Thus, 
12
Table 3. Thresholds for tropospheric ozone in Spain, according to Royal Decree 1796/2003
  
  Threshold Value Reference period
 
 Threshold for population  
 information 180 μg/m3 Hourly average
 
   Hourly average. For immediate
 Population alert threshold 240 μg/m3 action plans, evaluation is made
   during 3 consecutive hours
 
   Mean mobile 8-hourly without  
   maximum recovery of each day,
 Protection of health 120 μg/m3 cannot be exceeded more than 25 days    
   per calendar year on average in
   a period of 3 years  
 
 Protection of vegetation AOT40 = 6.000 μg/m3 h Hourly values from May to July
 
 Protection of forests AOT40 = 20.000 μg/m3 h Hourly values from April to 
   September
 
 Material damage 40 μg/m3 Calendar year
AOT40 will be the sum of the difference between hourly concentrations in excess of 80 μg /m3 (= 40 parts per 1000 million) and 
80 μg /m3 in the course of a given period, using only the hourly values measured between 8.00 and 20.00 hours.  
Figure 1. Simplifi ed representation of the nitrogen compounds cycle in 
an urban environment (taken from [4]).
Release into the atmosphere
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 and ozone levels and visits to the emergency service 
due to asthma attacks. In Madrid (Spain), Galán et al. [13] 
reported an identical association with the same two pollutants 
and with PM
10
; in addition, these authors simultaneously 
monitored pollen levels - concluding that the observed effect 
is independent of the atmospheric concentrations of pollen.
The experimental studies conducted on NO
2
 have yielded 
a range of results. Thus, for example, it has been reported that 
brief exposure to low levels of NO
2
 can induce changes in 
bronchial hyper-responsiveness in some asthmatic patients, 
but not in all of them [14] - though these fi ndings have not 
been reproduced in other studies using similar methodology 
[15] or higher concentrations of NO
2
 [16]. This could be 
due at least in part to the concentration used, since high 
concentrations (up to 910 mm/m3) yield effects in terms of 
bronchial hyper-responsiveness and lung function in both 
asthmatics and normal subjects [17]. In a later study, the 
same authors concluded that exposure to up to 500 mm/m3 of 
NO
2
 has little effect upon bronchial hyper-responsiveness in 
patients with mild asthma [18]. Another study, conducted in 
patients with moderate and severe asthma and involving NO
2
 
concentrations of up to 0.6 ppm, in another different zone, 
reported no effect [19]. On the other hand, it has been reported 
that prior exposure to NO
2
 is able to increase late bronchial 
responses induced by allergen [20].
1.2. Mechanisms of action. Although there are studies 
indicating that exposure to NO
2
 - a compound with important 
oxidative capacity - can induce airways infl ammation, there 
is no clearly demonstrated underlying mechanism of action 
capable of accounting for such effects. Some studies in healthy 
volunteers have shown that repeated exposure to NO
2
 induces 
neutrophilic infl ammation of the airways that remains for as 
long as the changes in pulmonary function persist [21,22]. 
In an in vitro study involving human bronchial cells from 
healthy volunteers, it was seen that NO
2
 exposure induced 
an increase in the levels of NO and IL-8, and the appearance 
of other infl ammatory cytokines [23]. The role of NO in the 
induction of cytokines and proinfl ammatory molecules has 
recently been confi rmed [24]. In an interesting study in healthy 
non-smoking volunteers exposed to NO
2
 and subjected to 
fi brobronchoscopy with the obtainment of a biopsy, increased 
expression of IL-5, IL-10, IL-13 and ICAM-1 was recorded 
[25]. The authors suggested that the observed increase in Th2 
cytokines could exert a “proallergic” effect upon the respiratory 
epithelium, while the increase in ICAM-1 could facilitate the 
development of viral processes - since this adhesion molecule 
is the principal receptor for rhinoviruses and respiratory 
syncytial virus (RSV). 
2. Ozone
Tropospheric ozone is principally formed from a series 
of reactions involving the participation of ultraviolet light, 
nitrogen oxides and organic compounds. These reactions can 
last from hours to days, depending on the organic compounds 
involved. Once formed, ozone can persist for several days; as 
a result, the levels found in a given area may depend upon the 
emissions of NO
X
 and organic compounds that may have taken 
place hundreds or even thousands of kilometers away. At local 
level, ozone can react with NO to produce NO
2
, resulting in 
a reduction in ozone levels. This is why ozone concentration 
tends to be lower in the center of cities with intense traffi c, 
and higher in nearby suburban and rural zones. Normally, the 
highest ozone concentrations are found downwind from the 
point where ozone is produced. In some regions, atmospheric 
recirculation phenomena may cause the air to remain in one 
given zone for several days. As a result of its photochemical 
origin, ozone concentrations are higher in the summer 
months and in the afternoon hours. Figure 2 depicts the ozone 
formation process. 
In most of Europe, the mean annual baseline levels 
range from 60-80 mg/m3, with scant variation, and are 
independent of the overlying photochemical peaks [26]. To 
these levels photochemical episodes characterized by high 
ozone concentrations may be added. This is partly dependent 
upon the ozone transported from the stratosphere, and in 
part upon the ozone produced in the troposphere from both 
anthropogenic and natural sources (in approximately equal 
proportions).
2.1. Effects of ozone.Ozone is a potent antioxidant that 
can react with an important range of cellular components. 
Specifi cally, in the respiratory setting, its capacity to induce 
alterations depends on the concentration, duration of exposure, 
pattern of exposure, and respiratory minute volume [27]. 
Generally, the effects are more notorious with intermittent 
exposures than as a consequence of continuous exposure.
Figure 2. Ozone formation. Ozone is produced by a complex atmospheric 
process involving the participation of nitrogen oxides, organic compounds, 
and sunlight. Abundant nitrogen monoxide (NO) is produced in cities - 
the great majority by motor vehicles. NO reacts with ozone (O3) present 
in the air, giving rise to nitrogen dioxide (NO2). This effectively gives 
rise to a decrease in ozone levels. Winds in turn can transport this NOX 
- rich air towards rural areas. In this setting, organic compounds of both 
natural and anthropogenic origin form peroxy radical (RO2·), with an 
uncoupled electron, which makes them enormously reactive. In the rural 
setting, sunlight breaks down NO2, giving rise to NO and O. The latter 
in turn reacts with molecular oxygen to yield O3. On the other hand, 
NO reacts with the peroxy radicals to give rise to NO2. Part of the O3 is 
removed through reaction with NO. The amount thus lost depends on 
the concentration of RO2 radicals.
Sunlight
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The studies that evaluate the effects of ozone generally 
indicate that exposure to this form of oxygen impairs lung 
function. Thus, in studies among healthy volunteers, and 
in addition to irritative cough and retrosternal pain during 
inspiration, a reduction is seen in vital capacity (VC), forced 
expiratory volume in one minute (FEV1) and lung resistances, 
together with an increase in respiratory frequency [26] - though 
these responses show important interindividual variability [28]. 
The effects of ozone exposure increase with physical exercise 
[29]. This happens, for example, on sunny days in summer, in 
the presence of high ozone pollution levels. 
Patients with respiratory diseases are more susceptible 
to the effects of ozone. Epidemiological studies show that 
exposure to ozone - in particular under conditions of oxidizing 
air pollution, as in summer - is associated with asthma 
exacerbation, an increased number of hospital admissions and 
emergency care visits because of asthma, and with increased 
medicine use among asthmatics [12,30-34]. The available data 
suggest that chronic ozone exposure can reduce the pulmonary 
function values in children [35].
Prior ozone exposure produces an increase in bronchial or 
nasal response to allergens [36]. It also has been reported that 
ozone exposure prior to a bronchial provocation or challenge 
test with allergen increases the number of eosinophils in the 
induced sputum [37]. Nevertheless, it also has been reported 
that exposure to ozone induces no changes in bronchial hyper-
responsiveness to methacholine [38].
2.2. Mechanisms of action. Regarding the possible 
mechanisms, it has been seen that the inhalation of ozone is 
able to induce an infl ammatory response, with an increase 
in neutrophil count and proteins in bronchoalveolar lavage 
(BAL) or sputum. This in turn is more intense in asthmatics 
than in normal individuals, though the lower airways 
symptoms and changes in lung function are not much 
greater in asthmatics than in normal subjects [38,39]. Other 
markers of pulmonary damage induced by ozone have been 
described, such as lactate dehydrogenase, PGE
2
 or IL-8 [40]. 
Other authors have reported an increase in the number of 
neutrophils, IL-8 and oncogene-alpha related to growth in 
the bronchoalveolar lavage of healthy individuals exposed to 
ozone in the course of physical exercise, though no increase 
has been seen in infl ammatory markers in the bronchial 
biopsy [41]. It has been described that lipid ozonization could 
give rise to the release of mediators capable of triggering an 
infl ammatory process [42]. On the other hand, it is believed 
that the C-fi bers, through the release of mediators - including 
possibly substance P - could be responsible for the effects of 
ozone [43]. This mechanism would form part of the protective 
pulmonary response to irritant agents. 
Some studies have reported that antioxidant ingestion can 
protect against the acute effects of ozone upon lung function, 
but not upon the associated infl ammatory response [44-46]. 
On the other hand, a study in healthy individuals showed that 
inhalatory budesonide at high doses does not protect against 
the effects of ozone upon lung function [47]. It likewise did 
not protect against the effects upon lung function in groups of 
patients with mild asthma - though the drug did reduce IL-8 
levels and the number of eosinophils in the induced sputum 
samples [48].
3. Particulate matter
The term “particulate matter” refers to the solid particles 
and/or droplets of variable size found in suspension in the air. 
The size can vary greatly, from particles measuring less than 
0.001 μm to pollen and spores measuring 2-50 μm, and large 
particles of up to 1000 μm. PM can be primary (when emitted 
directly into the atmosphere from anthropogenic or natural 
sources) or secondary (when formed in the atmosphere as a 
result of oxidation and other chemical reactions from sulfur 
dioxide, nitrogen oxides and volatile organic compounds). The 
secondary particles are fundamentally of anthropogenic origin. 
In most European countries, industrialization and intense 
traffi c have caused anthropogenic sources to predominate, 
particularly in the urban setting. These sources are similar 
throughout the continent. The most important sources are motor 
vehicles, energy production plants, combustion processes 
(industrial and residential), loading and unloading processes, 
mining, fi re of human origin and - in certain concrete locations 
- construction and stone quarry work. The main natural sources 
are marine spray and the wind-induced resuspension of soil 
particles. In the Mediterranean basin and in the Atlantic 
archipelagos (Canary Islands, Azores), dust from the Sahara 
and emissions of volcanic origin can constitute important 
sources of particles [49].
Basically, PM is composed of a black carbon core upon 
which a series of chemical and physical components deposit. 
Size and chemical composition are regarded as the principal 
characteristics of PM. In consonance, PM
10
 is defi ned as 
the mass of particles with an aerodynamic diameter of less 
than 10 μm per unit volume (μg/m3) - these being regarded 
as the breathable particles. The particles of larger size reach 





, with diameters of under 2.5 and 
1.0 µm, respectively) are able to reach the alveolar region. It 
is common to designate PM
2.5
 as the fi ne fraction, and PM
2.5-10
 
as the large fraction [50]. The fi ne fraction contains most of 
the acid and mutagenic activity, and accounts for most of the 
mass. Recently, the effects of ultrafi ne natural particles are 
being taken into consideration (<0.1 μm) [51,52], along with 
those of nanoparticles (<0.1 μm) - taken to represent those of 
industrial origin [53]. However, the detection of PM
0.1
 is still 
in the very early stages.
 3.1. Effects of PM. The World Health Organization (WHO) 
has established that there is a causal relationship between PM 
exposure and health effects - though no causal correlation to any 
concrete PM component can be established. Nevertheless, it can 
be affi rmed that the fi ne fraction (PM
2.5
) is more deleterious than 
the larger particle fractions. The main characteristics accounting 
for PM toxicity are the metal contents, the presence of aromatic 
polycyclic hydrocarbons and other organic components, 
endotoxin content, and an either small (under 2.5 μm) or very 
small particle size (under 0.1 μm) [35].
One of the most signifi cant studies on the effect of PM upon 
respiratory illnesses was carried out between 1985 and 1988 
by Pope, in the Utah valley [54]. This area was characterized 
by the presence of a steel laminating plant that constituted the 
principal source of PM
10
, and which was closed down from 
14 
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August to September 1987, as the result of a labor strike. 
This made it possible to compare the admissions due to lung 
diseases - including asthma - with the levels of such particles. 
The study concluded that PM
10
 levels were markedly associated 
with hospital admissions, particularly in the case of children 
and patients with asthma or bronchitis. These effects have 
since been confi rmed in different parts of the world by other 
studies [55-62].
3.2. Mechanisms of action. It can be considered that the 
effects of PM depend on the action exerted by the central core 
on one hand, and by the chemicals transported by the particles 
on the other - including aromatic polycyclic hydrocarbons 
and quinolones, and transition metals such as chromium, 
vanadium, nickel, copper, cobalt and iron [63]. Overall, the 
particles as such possess intrinsic adjuvant activity capable of 
increasing antibody response, including IgE, with the induction 
of infl ammation [64,65] - while the associated substances exert 
different effects upon immune allergic responses [66-68]. In this 
context, Granum and Løvik consider that the particles as such 
behave as a general “motor” for the production of antibodies, 
while the adhered chemical substances, and possibly other 
factors such as load, structure and size, are able to direct the 
effect towards either a Th1 or Th2 response [69].
In animal models it has been seen that PM
10
 possess free 
radical activity and can cause epithelial damage and pulmonary 
infl ammation [62,70]. They are reportedly able to induce 
the release of IL-8, MIP-2 and IL-6 in human alveolar cells 
[71]. In the allergological setting, it has been reported that 
particulate matter can act as an adjuvant and increase specifi c 
IgE production in animal models [72].
3.3. Diesel emission particles (DEPs). As has been 
commented above, motor vehicles are one of the most important 
sources of polluting agents, including PM. The most important 
source in relation to motor vehicles corresponds to diesel 
engines. In this sense, diesel engines can emit up to 100 times 
more particles than gasoline engines. Furthermore, the number 
of diesel-driven vehicles has increased considerably, due to 
their increased effi cacy and durability, and the lower cost of 
diesel fuel. Diesel exhaust particles are composed of a central 
core to which hundreds of chemical compounds and transition 
metals adhere. These in turn are responsible for the adjuvant and 
proinfl ammatory properties of DEPs. Most DEPs are classifi ed 
as fi ne (2.5-0.1 μm) or ultrafi ne particles (<0.1 μm). The smaller 
particles are considered to have a relatively greater surface, and 
therefore may contribute a larger number of chemical agents 
- resulting in a more marked biological effect [73].
Since precise determination of environmental DEP 
exposure in vivo in humans has been complicated by a lack 
of biomarkers, very few studies have analyzed the effects of 
diesel vehicle exhaust considered isolatedly [74]. As a result, 
exposure to moving traffi c has been used as an approximation. 
Such exposure has been related to respiratory symptoms, 
asthma, and allergic disorders in different populations [75-
79]. In a very recent study conducted in a large sample of 
children, diminished lung function has been recorded in 
children living closer to intense traffi c than in those living at 
a distance from such traffi c - regardless of air quality [80]. 
Studies have been made of the effects of DEPs upon many 
types of cells, and in healthy subjects (reviewed in depth 
in [81]). Basically, DEPs are able to act upon many cells 
- inducing the expression of different infl ammatory markers 
(Table 4). In healthy individuals, DEP inhalation increases 
the number of infl ammatory cells in the airways and raises 
circulating neutrophil and platelet counts, and histamine. In 
turn, the expression of certain cytokines, chemokines and 
adhesion molecules also increases, while macrophage function 
decreases and respiratory tract resistance increases. In patients 
with asthma, DEPs have been reported to increase nonspecifi c 
bronchial hyper-responsiveness, airways resistance, and IL-6 
in sputum [82]. In another interesting study, Holgate et al. 
performed bronchial provocation with DEPs in healthy subjects 
and in asthmatics - both groups showing a discrete increase in 
airways resistance [83]. In healthy individuals they reported 
an increase in neutrophils in bronchoalveolar lavage, with 
IL-8 elevation in the latter and also in the biopsy. However, 
the asthmatics showed no change in the parameters, with the 
exception of increased IL-10 expression in the biopsy. Studies 
have also been made of DEP effects upon allergic responses. 
Thus, it has been seen that DEPs are able to act as adjuvants 
in the mucosal membranes, in the context of a de novo IgE-
mediated response, and thus increase allergic sensitization [84]. 
Furthermore, nasal provocation with DEPs and Ambrosia can 
induce an isotype change towards IgE, with a rise in the local 
levels of this immunoglobulin [85]. Nasal provocation with 
DEPs can increase the expression of Th2 cytokines [86]. It also 
has been seen that in application to basophils, DEPs can induce 
histamine and IL-4 release, independently of the administration 
of an allergen [87]. On the other hand, in a study of patients 
with dust mite allergy, the intranasal administration of DEPs 
prior to provocation with the allergen induced higher symptoms 
scores, required a fi fth of the amount of allergen, and induced a 
three-fold higher histamine release than when provocation was 
limited to the allergen alone [88]. DEPs have been shown to 
be able to induce proinfl ammatory mediator release by human 
bronchial epithelial cells [89]. Moreover, these cells have been 
seen to behave differently in asthmatic patients versus healthy 
individuals, in terms of the amount and types of mediators 
released, and of sensitivity to DEPs [90].
 
Genetic aspects
Although the responses to the different environmental 
pollutants are reproducible, there is marked interindividual 
variability. This has been related to the intervention of possible 
genetic factors. These effects have been investigated in animal 
models fundamentally in relation to ozone [91]. Few studies 
have been conducted in humans. In this context, Wintentor et 
al. reported an association between a certain polymorphism 
of the promoter region of the TNFA gene and the response to 
SO
2
 in asthmatic patients - though no such association was 
observed with other genes such as IL4RA, B2ADR, CC16 or 
LTA [92]. In turn, Yang et al. observed an association between 
the same TNFA gene polymorphism and ozone response 
[93]. Polymorphisms in “antioxidant” genes have also been 
evaluated. Specifi cally, in healthy volunteers exposed to ozone 
during physical exercise, the maximum risk genotypes of the 
genes NQO1 (nicotinamide adenine dinucleotide (phosphate) 
15
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reduced quinone oxidoreductase) and GSTM1 (glutathione-S-
transferase µ1) - which imply excessive free radical production 
- have been correlated to a greater reduction in lung function, 
and to an increase in infl ammatory markers [94,95]. In a study 
conducted in children in Mexico city, continuously exposed 
to high ozone levels, certain genotypes of the aforementioned 
genes were seen to entail a lesser risk of developing asthma 
[96]. In another placebo controlled study conducted among 
155 children in the same city, involving the administration of 
vitamin E and C and antioxidants, it was seen that children 
nulligenic for a certain polymorphism of the GSTM1 gene 
presented greater lung function reduction when given 
placebo. Moreover, these children benefi ted more from the 
administration of antioxidants [97]. In a later study, the same 
authors found that asthmatic children nulligenic for a certain 
polymorphism of the GSTM1 gene and with Val/Val in GSTP1 
presented greater susceptibility towards the development of 
respiratory symptoms related with ozone exposure [98].
Conclusions
Technical and industrial development has led to environmental 
pollution problems, with deleterious effects upon health. In the 
last few decades special attention has focused on pollutants 
- mostly of anthropogenic origin. Epidemiological studies 
have revealed a statistical association between the levels of 
a pollutant or series of pollutants and the exacerbation of 
certain allergic respiratory diseases, among other processes. 
These data are reinforced by the fi ndings in animal models, 
and by the experimental results of in vitro and in vivo studies 
in humans. The main pollutants are nitrogen dioxide, ozone, 
and suspended particles. Nitrogen dioxide is able to induce 
respiratory symptoms and bronchial infl ammation at high 
doses, in healthy volunteers. In the case of asthmatics, and 
although there may be debate on the matter, it seems that 
exposure to this pollutant can increase the symptoms, bronchial 
hyper-responsiveness and bronchial infl ammation at lower 
doses. Ozone, which presents a complex production process, is 
a potent antioxidant that can induce changes in lung function. 
The most susceptible populations are children and patients 
with respiratory diseases. Generally, the effects are more 
notorious with intermittent exposures than as a consequence 
of continuous exposure. Particulate matter in suspension 
is composed of a central core to which different chemical 
compounds adhere. Size is important in relation to the effect 
of such particles, and in this sense, attention is increasingly 
centering on the smallest particles - especially those under 2.5 
and 0.1 μm in size. Their effects depend both on the central 
core and on the associated particles. Special mention must be 
made of diesel emission particles (DEPs). Apart from their 
effects on lung function, they are able to act as adjuvants in 
allergic reactions.
Lastly, some polymorphisms have been described - 
generally related to oxidative pathways - that could imply a 
protective or deleterious effect in relation to pollutants.
Table 4. Direct effects of diesel particles (DEPs) or of their extracts upon different cells (taken from [81])  
Nasal and bronchial    Increased chemokine and cytokine expression (IL-8,    
epithelial and endothelial cells   eotaxin, RANTES, GM-CSF, IL-6)
       Increased receptor H
1
 expression
       Increased ICAM-1 expression
 
Eosinophils     Increased adherence to nasal epithelial cells
  Induction of degranulation
 
Mast cells Increased IgE induced histamine release
  Increased production of cytokines IL-4 and IL-6
 
Basophils Induction of histamine release in absence of IgE
  Increased production of IL-4
Peripheral blood Induction of chemokine production (IL-8, RANTES)
mononuclear cells In combination with allergen, increases in IL-8, RANTES and TNF-α
B cells Increased IgE production after stimulation with IL-4 and anti-CD40
Monocytes - macrophages Modulation of cytokine production (inhibition of the production  
  of IL-12p40)
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